Healthcare

Request for TOC Request for Sample
BUY NOW

Global Imaging Tracers Market – Industry Trends and Forecast to 2028

Healthcare | Upcoming Report | Feb 2021 | Global | 350 Pages | No of Tables: 60 | No of Figures: 220

Report Description

Global Imaging Tracers Market, By Application (Oncology, Cardiology, Gastrointestinal Disorders, Neurology Disorders, Cancer, Musculoskeletal Disorders, Others), Modality (CT, PET), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

Get Exclusive Sample Copy of this Report Here

Market Analysis and Insights : Global Imaging Tracers Market

The imaging tracers market is expected to witness market growth at a rate of 4.65% in the forecast period of 2021 to 2028. Data Bridge Market Research report on imaging tracers market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The technological advancement in the medical imaging industry is escalating the growth of imaging tracers market.

Imaging tracers refer to as radioactive chemical compounds that are utilized for the visualization and monitoring the chemical reactions in the cellular and molecular levels. These imaging tracers assist in enabling the visualization of organs, cells when they are being scanned from a CT or PET system. These tracers are injected intravenously inside the human body. After the injection, the patients are scanned through the devices where the visualization of organs and cellular are enhanced due to the reaction of isotopes with the molecules.

The rise in investment for the research and development activities to enhance the quality of treatment and increasing prevalence and adoption of radioactive imaging tracers in diagnostics and clinical applications owning to their increased efficiency and effectiveness are the major factors driving the imaging tracers market. The growing prevalence of chronic diseases such as cancer, extensive technological advancements in imaging techniques and the growing demand for preventive care and early diagnosis among consumers accelerate the imaging tracers market growth. The increasing number of older adults, the growth in demand for minimally invasive equipment and the use of the method as a powerful tool for determining the stage of many cancer types influence the imaging tracers market. Additionally, growth in geriatric population, change in the lifestyle, and surge in healthcare expenditure, increasing research and development activities and high investment in research projects positively affect the imaging tracers market. Furthermore, technological advancement and emerging economies extends profitable opportunity to the imaging tracers market players in the forecast period of 2021 to 2028.  

On the other hand, the implementation of strict regulations governing preclinical research and significant installation and operational costs associated with preclinical imaging modalities are expected to obstruct the imaging tracers market growth. Technological and procedural drawbacks associated with standalone preclinical imaging systems are projected to challenge the imaging tracers market in the forecast period of 2021 to 2028.

This imaging tracers market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on imaging tracers market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Imaging Tracers Market Scope and Market Size

The imaging tracers market is segmented on the basis of application and modality. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

  • On the basis of application, the imaging tracers market is segmented into oncology, cardiology, gastrointestinal disorders, neurology disorders, cancer, musculoskeletal disorders and others.
  • On the basis of modality, the imaging tracers market is segmented into CT and PET.

Global Imaging Tracers Market Country Level Analysis

The imaging tracers market is analyzed and market size insights and trends are provided by country, application and modality as referenced above.        

The countries covered in the global imaging tracers market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the imaging tracers market because of the increasing incidence rate of cancer and other neurological diseases, technological advancement in the field of radio pharmacy and rise in cyclotron base production of radio isotopes and installation of the new cyclotron.

The country section of the imaging tracers market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The imaging tracers market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for imaging tracers market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on imaging tracers market. The data is available for historic period 2011-2019.

Competitive Landscape and Imaging Tracers Market Share Analysis

The imaging tracers market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to imaging tracers market.

The major players covered in the imaging tracers market report are Bayer AG, GENERAL ELECTRIC, Eisai Co., Ltd., DAIICHI SANKYO COMPANY, LIMITED, 3B Pharmaceuticals, Advanced Accelerator Applications, Blue Earth Diagnostics Limited, Curium, FluoroPharma Medical, Inc., Ground Fluor Pharmaceuticals, Inc., Ipsen Group, Cell>Point, L.L.C, KP Pharmaceutical Technology Inc., Alliance Medical and Vizient Inc. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-

Table of Content

Please fill in the below form for detailed Table of Content

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Table

Please fill in the below form for detailed List of Table

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

List of Figure

Please fill in the below form for detailed List of Figure

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country

View Infographics

Please fill in the below form for detailed Infographics

First name is required
Last name is required
Please enter Contact No.
Email is required
Please enter job tital
Please enter company name
Please select country
CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19